Integrating Single-Cell Foundation Models with Graph Neural Networks for Drug Response Prediction
By: Till Rossner , Ziteng Li , Jonas Balke and more
Potential Business Impact:
Helps pick the best medicine for sick cells.
AI-driven drug response prediction holds great promise for advancing personalized cancer treatment. However, the inherent heterogenity of cancer and high cost of data generation make accurate prediction challenging. In this study, we investigate whether incorporating the pretrained foundation model scGPT can enhance the performance of existing drug response prediction frameworks. Our approach builds on the DeepCDR framework, which encodes drug representations from graph structures and cell representations from multi-omics profiles. We adapt this framework by leveraging scGPT to generate enriched cell representations using its pretrained knowledge to compensate for limited amount of data. We evaluate our modified framework using IC$_{50}$ values on Pearson correlation coefficient (PCC) and a leave-one-drug out validation strategy, comparing it against the original DeepCDR framework and a prior scFoundation-based approach. scGPT not only outperforms previous approaches but also exhibits greater training stability, highlighting the value of leveraging scGPT-derived knowledge in this domain.
Similar Papers
scDrugMap: Benchmarking Large Foundation Models for Drug Response Prediction
Artificial Intelligence
Finds best cancer drugs for patients.
DeepSeq: High-Throughput Single-Cell RNA Sequencing Data Labeling via Web Search-Augmented Agentic Generative AI Foundation Models
Genomics
Helps computers understand cell data automatically.
A Geometric Graph-Based Deep Learning Model for Drug-Target Affinity Prediction
Biomolecules
Finds best medicines for diseases faster.